% | $
Quotes you view appear here for quick access.

Nektar Therapeutics Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • gladpick gladpick Jul 28, 2011 11:48 AM Flag


    ["It seems to me the BC data is sufficient to justify a further controlled PII trial, but it's ridiculous to begin an 840-patient PIII trial in MBC based on the results in a 16-patient subgroup of a single-arm PII study."

    Completely agree. Some serious data mining was required to construct this phase 3 program. A 16-patient sub-sub-population? Come on, this is statistics 101]
    Based on available info, HR has a 4 year degree in ACCOUNTING and no science education. He must be a good CON man to get to where he is with NKTR.

    It is true that some large drug companies are run by people who have no science education. But most of them have competent scientists who help make drug development decisions. Apparently HR has surrounded himself with a bunch of bozos. I wonder if that is why Lorianne has diapppeared from the list of management.

15.20-0.19(-1.23%)Jul 22 4:00 PMEDT